Search results
Results from the WOW.Com Content Network
Tuberculosis spreads through the air from one person to another. Someone with an active infection can put the germs into the air when they cough, speak, or sing. Those germs can hang out in the ...
Directly observed treatment, short-course (DOTS, also known as TB-DOTS) is the name given to the tuberculosis (TB) control strategy recommended by the World Health Organization. [1] According to WHO, "The most cost-effective way to stop the spread of TB in communities with a high incidence is by curing it.
There are several ways that drug resistance to TB, and drug resistance in general, can be prevented: [34] [35] Rapid diagnosis & treatment of TB: One of the greatest risk factors for drug-resistant TB is problems in treatment and diagnosis, especially in developing countries. If TB is identified and treated soon, drug resistance can be avoided.
In 2017, the Indian government announced its intention to eliminate tuberculosis in the country by 2025. The previous year, it accounted for 27 percent of tuberculosis cases and 29 percent of deaths worldwide, making it the highest burden country for both tuberculosis and multidrug-resistant tuberculosis. [11] [12]
This can entail anything from turning up late to work, using AI on the job, or “quiet vacationing.” ... as only 22% of Gen Z feel the same way about running late. In fact, nearly half believe ...
As such, a person diagnosed with latent TB can safely assume that, even after treatment, they will carry the bacteria – likely for the rest of their lives. Furthermore, "It has been estimated that up to one-third of the world's population is infected with M. tuberculosis, and this population is an important reservoir for disease reactivation."
As of October 2006, "Extensively drug-resistant tuberculosis" (XDR-TB) is defined as MDR-TB that is resistant to quinolones and also to any one of kanamycin, capreomycin, or amikacin. [76] The old case definition of XDR-TB is MDR-TB that is also resistant to three or more of the six classes of second-line drugs. [ 77 ]
Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch . [ 1 ] As of 2021, the only effective tuberculosis vaccine in common use is the Bacillus Calmette-Guérin (BCG) vaccine, first used on humans in 1921.